CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Arcutis gets FDA review for Zoryve 0.05% label expansion

RegulatoryZoryve 0.05%Positive
AI Analysis

Summary

Arcutis has received FDA review for a label expansion of Zoryve 0.05%. Specific indication details and timeline for the review are not provided in the article.

Importance:5/10
Sentiment:
0.50
FDALabel ExpansionRegulatory
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on July 8, 2026 2:56 PM

Read Original